LEVOYA

Levoya is a pre-clinical stage biotechnology company focused on the development of a novel platform for the oral delivery of biologics and other large molecules. As a portfolio company of InCube Labs, Levoya utilizes a proprietary mechanical delivery system designed to protect sensitive therapeutic payloads from the harsh environment of the gastrointestinal tract. The technology aims to facilitate the absorption of drugs that currently require injection, such as peptides and monoclonal antibodies, into the systemic circulation via an oral pill. By transforming the delivery of chronic therapies for conditions like diabetes and autoimmune diseases, Levoya seeks to significantly improve patient compliance and clinical outcomes. The company is currently advancing its platform through pre-clinical validation and optimization of its lead therapeutic candidates.